PL1771180T3 - Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową - Google Patents

Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową

Info

Publication number: PL1771180T3
Authority: PL; Poland
Prior art keywords: phase; calcitriol; spray; combination; composition
Prior art date: 2004-06-17

Application number

PL05763728T

Other languages

English (en)

Other versions

PL1771180T5 (pl

Inventor

Nathalie Willcox

Sandrine Orsoni

Original Assignee

Galderma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-17

Filing date

2005-06-15

Publication date

2008-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1771180(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-17 Priority claimed from FR0406616A external-priority patent/FR2871700B1/fr

2005-06-15 Application filed by Galderma Sa filed Critical Galderma Sa

2008-02-29 Publication of PL1771180T3 publication Critical patent/PL1771180T3/pl

2011-04-29 Publication of PL1771180T5 publication Critical patent/PL1771180T5/pl

Links

LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 2
GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title abstract 2
229960005084 calcitriol Drugs 0.000 title abstract 2
235000020964 calcitriol Nutrition 0.000 title abstract 2
239000011612 calcitriol Substances 0.000 title abstract 2
229960004703 clobetasol propionate Drugs 0.000 title abstract 2
CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000007921 spray Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Birds (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pulmonology (AREA)
Immunology (AREA)
Gerontology & Geriatric Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL05763728T 2004-06-17 2005-06-15 Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową PL1771180T5 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR0406616A FR2871700B1 (fr)	2004-06-17	2004-06-17	Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
US10/951,903 US20050281754A1 (en)	2004-06-17	2004-09-29	Sprayable compositions comprising a combination of pharmaceutical active ingredients, an alcohol phase and an oily phase
PCT/EP2005/007973 WO2005123091A1 (en)	2004-06-17	2005-06-15	Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
EP05763728A EP1771180B2 (en)	2004-06-17	2005-06-15	Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase

Publications (2)

Publication Number	Publication Date
PL1771180T3 true PL1771180T3 (pl)	2008-02-29
PL1771180T5 PL1771180T5 (pl)	2011-04-29

Family

ID=34982462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05763728T PL1771180T5 (pl)	2004-06-17	2005-06-15	Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową

Country Status (12)

Country	Link
EP (1)	EP1771180B2 (pl)
JP (1)	JP2008502646A (pl)
AT (1)	ATE376834T1 (pl)
AU (1)	AU2005253734B2 (pl)
BR (1)	BRPI0511387A (pl)
CA (1)	CA2567684A1 (pl)
DE (1)	DE602005003138T3 (pl)
DK (1)	DK1771180T4 (pl)
ES (1)	ES2296209T5 (pl)
PL (1)	PL1771180T5 (pl)
SI (1)	SI1771180T2 (pl)
WO (1)	WO2005123091A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2871697B1 (fr) †	2004-06-17	2007-06-29	Galderma Sa	Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
WO2007133747A2 (en) *	2006-05-15	2007-11-22	Wisconsin Alumni Research Foundation	PULMONARY DELIVERY OF 1α,25-DIHYDROXYVITAMIN D3 AND CO-ADMINISTRATION OF PARATHYROID HORMONE OR CALCITONIN
KR20110113664A (ko) *	2006-08-29	2011-10-17	테바 파마슈티컬 인더스트리즈 리미티드	비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US10265265B2 (en)	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition
EP2008651A1 (en)	2007-06-26	2008-12-31	Drug Delivery Solutions Limited	A bioerodible patch
KR101619077B1 (ko)	2010-06-11	2016-05-10	레오 파마 에이/에스	비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물
BR112013023458B1 (pt)	2011-03-14	2020-04-07	Drug Delivery Solutions Ltd	composição oftálmica, e, método para fabricar a composição oftálmica
EP3542788A1 (en)	2018-03-19	2019-09-25	MC2 Therapeutics Limited	Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4610978A (en)	1983-03-22	1986-09-09	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
FR2737118B1 (fr) *	1995-07-28	1997-09-05	Oreal	Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
FR2738745B1 (fr) *	1995-09-15	1997-10-24	Cird Galderma	Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
FR2740038B1 (fr) *	1995-10-20	1998-01-02	Lafon Labor	Composition pour l'administration transdermique
US5972920A (en) †	1998-02-12	1999-10-26	Dermalogix Partners, Inc.	Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
EP0966972B1 (en) *	1998-06-18	2003-09-24	Dow Corning France S.A.	Topical composition containing silicon gum
ES2388425T5 (es) *	1999-04-23	2020-02-12	Leo Pharma As	Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
DE10024413A1 (de) *	2000-05-19	2001-12-06	Mika Pharma Gmbh	Pharmazeutische und/oder kosmetische Zubereitung
US6579512B2 (en) *	2001-06-15	2003-06-17	Crutchfield, Iii Charles E.	Topical steroid spray
FR2848454B1 (fr)	2002-12-17	2007-03-30	Galderma Res & Dev	Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
FR2856301B1 (fr) *	2003-06-23	2007-08-03	Galderma Res & Dev	Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
AU2005253733A1 (en)	2004-06-17	2005-12-29	Galderma S.A.	Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase

2005
- 2005-06-15 CA CA002567684A patent/CA2567684A1/en not_active Abandoned
- 2005-06-15 JP JP2007515907A patent/JP2008502646A/ja not_active Ceased
- 2005-06-15 ES ES05763728T patent/ES2296209T5/es not_active Expired - Lifetime
- 2005-06-15 BR BRPI0511387-3A patent/BRPI0511387A/pt not_active IP Right Cessation
- 2005-06-15 AU AU2005253734A patent/AU2005253734B2/en not_active Ceased
- 2005-06-15 DK DK05763728.2T patent/DK1771180T4/da active
- 2005-06-15 AT AT05763728T patent/ATE376834T1/de active
- 2005-06-15 SI SI200530095T patent/SI1771180T2/sl unknown
- 2005-06-15 PL PL05763728T patent/PL1771180T5/pl unknown
- 2005-06-15 DE DE602005003138T patent/DE602005003138T3/de not_active Expired - Lifetime
- 2005-06-15 WO PCT/EP2005/007973 patent/WO2005123091A1/en not_active Ceased
- 2005-06-15 EP EP05763728A patent/EP1771180B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE602005003138D1 (de)	2007-12-13
AU2005253734A1 (en)	2005-12-29
DK1771180T4 (da)	2011-04-11
EP1771180B2 (en)	2011-01-05
PL1771180T5 (pl)	2011-04-29
DK1771180T3 (da)	2008-03-03
WO2005123091A1 (en)	2005-12-29
SI1771180T1 (sl)	2008-02-29
JP2008502646A (ja)	2008-01-31
DE602005003138T3 (de)	2011-07-14
EP1771180B1 (en)	2007-10-31
ES2296209T5 (es)	2011-04-19
EP1771180A1 (en)	2007-04-11
SI1771180T2 (sl)	2011-02-28
BRPI0511387A (pt)	2007-12-04
DE602005003138T2 (de)	2008-08-14
AU2005253734B2 (en)	2011-02-17
ATE376834T1 (de)	2007-11-15
ES2296209T3 (es)	2008-04-16
CA2567684A1 (en)	2005-12-29

Publication	Publication Date	Title
CY1107033T1 (el)	2012-09-26	Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
MXPA05013232A (es)	2006-03-09	Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
WO2010072958A3 (fr)	2012-01-12	Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
AR046642A1 (es)	2005-12-14	Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
WO2010021607A3 (en)	2010-06-03	Pharmaceutical formulation
PT1686972E (pt)	2008-04-23	Composição pulverizável para a administração de derivados da itamina d
WO2006060515A3 (en)	2006-08-17	System for improved percutaneous absorption of skin benefiting agents
WO2008074833A3 (en)	2008-08-28	Compounds
NO20083759L (no)	2008-10-21	Doserings aerosoler for administrering av farmasoytiske preparater
SI1771180T1 (sl)	2008-02-29	Zmes v obliki prsila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza inoljna faza
TNSN07203A1 (en)	2008-11-21	Pharmaceutical compositions for the treatment of cellulite
WO2010018385A3 (en)	2011-04-07	Chemical composition for skin care formulations
WO2008050157A3 (en)	2008-09-25	Ozonated oil formulations
SI1893237T1 (sl)	2010-03-31	Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine
WO2007077318A3 (fr)	2007-10-11	Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
PL1868631T3 (pl)	2010-10-29	Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
WO2007003771A3 (fr)	2007-04-19	Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
WO2008125771A3 (fr)	2009-06-11	Utilisation cosmetique d'un extrait de debaryomyces hansenii
WO2005037772A3 (fr)	2005-09-01	NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
AR048672A1 (es)	2006-05-17	Tabletas de desintegracion que comprenden licarbazepina
WO2005056510A3 (en)	2005-08-11	Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
WO2006103119A3 (en)	2007-02-15	Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
WO2007003773A3 (fr)	2007-04-05	Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
MX2007013449A (es)	2008-01-21	Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo.
WO2005004878A3 (en)	2005-04-21	Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically